Yudi Zhang
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasms.
Journal: Pathology, research and practice
Published: September 02, 2024
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31.
Journal: British journal of haematology
Published: February 27, 2024
Impact of the International Consensus Classification of myelodysplastic syndromes.
Journal: British journal of haematology
Published: October 21, 2022
Distinguishing myelodysplastic syndromes with moderate-to-severe bone marrow fibrosis from triple-negative primary myelofibrosis based on clinical and genetic covariates.
Journal: Hematological oncology
Published: October 20, 2022
IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes.
Journal: Experimental hematology & oncology
Published: September 08, 2022
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms.
Journal: Leukemia
Published: July 21, 2022
ASXL2 mutated myelodysplastic syndrome in a novel germline G6b variant.
Journal: Leukemia research reports
Published: January 23, 2022
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.
Journal: Blood cancer journal
Published: April 23, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026